APRETUDE (cabotegravir) is a prescription medicine used for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (at least 35 kg).
APRETUDE is manufactured by GlaxoSmithKline.
Administration and Dosage:
APRETUDE is given every other month by a healthcare provider after initiation injections have been given 1 month apart for 2 consecutive months
Common Side Effects:
Pain, tenderness, hardened mass or lump, swelling, bruising, redness, itching, warmth, loss of sensation at the injection site, abscess, and discoloration; diarrhea; headache; fever; tiredness; sleep problems; nausea; dizziness; passing gas; stomach pain; vomiting; muscle pain; rash; loss of appetite; drowsiness; back pain; or upper respiratory infection
These are not all the possible side effects of APRETUDE. Call your healthcare provider for medical advice about side effects
More Information:
Please read the full Prescribing Information for ACTEMRA® and discuss any questions you have with your doctor.
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
Indication:
APRETUDE is indicated to treat:
- HIV
